The performance of 54 subjects genetically at risk for Huntington's disease was examined in double-blind fashion on a series of computerized tests from the Cambridge Neuropsychological Test Automated Battery. None of the subjects exhibited clinical movement disorder characteristic of Huntington's disease. Of the 54 subjects, 22 were Huntington's disease mutation carriers and 32 were non-carriers. On a comprehensive battery of neuropsychological tests previously shown to be sensitive to the early stages of clinical Huntington's disease, Huntington's disease mutation carriers exhibited highly specific cognitive deficits. In particular, Huntington's disease mutation carriers performed significantly less well
Introduction
Perhaps the most controversial issue in the neuropsychological study of Huntington's disease is the issue of detecting possible preclinical manifestations of the disease. This is an issue of profound importance given current developments in treatment strategies for the disease. A detailed knowledge of the time course of CNS dysfunction in Huntington's disease has important implications for the administration of possible therapies aimed either at replacing damaged neural tissue (Dunnett, 1995) or at slowing the time-course of mechanisms of cell death or disabling these mechanisms (Kieburtz et al., 1996) .
Over the years, a number of research groups have examined cognitive functioning in subjects at risk for developing
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than non-carriers, matched for age and IQ, on tests of attentional set shifting and semantic verbal fluency. Furthermore, performance on these two tests was significantly correlated, even after partialling out the effects of age and IQ. It is suggested that these cognitive impairments relate to a common deficit in inhibitory control mechanisms, under the control of striatofrontal mechanisms, and that such a deficit is present in Huntington's disease mutation carriers prior to the onset of definite motor symptomatology. The implications for the nature of the cognitive decline seen in Huntington's disease, and possible future treatment strategies, are discussed.
Huntington's disease. Unfortunately, research published prior to the discovery of the Huntington's disease mutation (Huntington's Disease Collaborative Research Group, 1993) is difficult to interpret, given that 100% classification of genetic status in at-risk individuals was not possible (for reviews, see Brandt and Butters, 1996) . Although some earlier studies which employed DNA linkage analysis using the G8 probe (Gusella et al., 1983) to determine high (Ͼ95%) versus low (Ͻ5%) risk of carrying the Huntington's disease mutation found evidence for preclinical cognitive impairment in Huntington's disease, most studies did not (e.g. Rothlind et al., 1993; Giordani et al., 1995) , and Brandt and colleagues (Strauss and Brandt, 1990; Brandt and Butters, 1996) have pointed out several flaws in those studies which did point towards preclinical cognitive dysfunction in Huntington's disease (e.g. Jason et al., 1988; Diamond et al., 1992) .
More recent research has provided some evidence for preclinical cognitive dysfunction in Huntington's disease, although the issue is far from being resolved. To date, eight studies have been published following identification of the Huntington's disease mutation and the introduction of polymerase chain reaction (PCR) assays for the Huntington's disease trinucleotide repeat expansion, comparing cognitive function in mutation-positive and mutation-negative at-risk subjects. Four of these studies report preclinical cognitive impairment in mutation carriers (Foroud et al., 1995; Rosenberg et al., 1995; Siemers et al., 1996; Gray et al., 1997) on measures of psychomotor speed, memory, and emotion recognition, whilst four studies report no differences between mutation-positive and mutation-negative subjects (Blackmore et al., 1995; Campodonico et al., 1996; GomezTortosa et al., 1996; de Boo et al., 1997) . There are a number of reasons for such discrepant findings, including differences in population sizes, mean age, test sensitivity, and the clinical criteria used to decide the presence/absence of clinical symptoms.
In contrast to the neuropsychological studies, neuroimaging studies have consistently pointed to basal ganglia compromise in preclinical Huntington's disease. PET studies have shown decreased basal ganglia glucose metabolism (Antonini et al., 1996) and dopamine receptor binding (Antonini et al., 1996; Weeks et al., 1996) in preclinical Huntington's disease mutation carriers, and Aylward et al. (1996) have shown using structural MRI that mutation carriers have reduced basal ganglia volumes many years before their predicted age of onset. These results thus suggest that basal ganglia damage is present preclinically in Huntington's disease, and also suggest the possibility that, given a sensitive enough cognitive marker, preclinical cognitive impairments may well be observable.
The purpose of the current study was to examine, in double-blind fashion, the performance of subjects at risk for Huntington's disease on a battery of neuropsychological tests which have proved to be sensitive to frontostriatal dysfunction . We employed a battery of tests covering a broad area of cognitive functioning, with particular emphasis on those functions considered to be vulnerable to clinical Huntington's disease , i.e. executive functions. In addition we assessed general intellectual function, against which more specific cognitive functions were compared. We hope that this study may help in clarifying some of the issues relating to possible preclinical cognitive impairment, and to the time course of cognitive dysfunction in Huntington's disease.
In particular, it was hypothesized that the visual discrimination learning/attentional set-shifting task of the Cambridge Neuropsychological Test Automated Battery (CANTAB) which has been shown to be highly sensitive to early stage clinical Huntington's disease , may prove to be useful in picking up possible preclinical cognitive dysfunction in Huntington's disease.
Method Subjects
Subjects were recruited from the Cambridge Huntington's Disease Clinic, a multidisciplinary clinic in which geneticists, neurologists, psychologists, psychiatrists, clinical nurse specialists and family support workers provide an integrated service for individuals and families with Huntington's disease. The clinic operates according to World Federation of Neurology guidelines for predictive testing of Huntington's disease (World Federation of Neurology, 1994) . The study received ethical permission from the Addenbrooke's Hospital Medical Ethics Committee, and all subjects gave written, informed consent.
All at-risk individuals attending the clinic underwent a standardized neurological examination based on the comprehensive neurological inventory designed for use in neuropsychiatric research (Chen et al., 1995) , plus the motor components of the United Huntington's Disease Rating Scale (Huntington Study Group, 1996) . Patients with 'soft' neurological signs (e.g. positive pout or glabellar tap) were not excluded from the study but subjects with abnormal movements or 'hard' signs (e.g. extensor plantars, cerebellar incoordination or gait instability) were excluded. Neurological assessments were performed by Professor J. R. Hodges and Dr A. E. Rosser, clinicians with a detailed knowledge of Huntington's disease. In the same session, subjects were seen for neuropsychological assessment (by A. D. Lawrence and Dr B. J. Sahakian). Following these assessments, consent was obtained and a blood sample taken for DNA analysis, in order to determine mutation carrier status by means of direct gene testing by the PCR, using an assay which excludes the polymorphic CCG repeats surrounding the CAG expansion (for details, see Rubinsztein et al., 1993) .
Of the subjects attending the clinic over a 3-year period, an unselected sample of 54 at-risk subjects free from clinical symptoms of Huntington's disease or other neurological disorder was obtained. Twenty-two of these subjects tested positive for the Huntington's disease mutation (36 or more repeats) (Rubinsztein et al., 1996) , and 32 tested negative. The groups will be designated at-risk-positive (AR ϩ ) and atrisk-negative (AR Ϫ ) respectively. The two groups did not differ significantly from each other in terms of age [t(52) ϭ -0.76, P ϭ 0.45], IQ estimated by the National Adult Reading Test (NART) (Nelson, 1982) [t(52) ϭ -0.17, P ϭ 0.87], or in terms of female : male ratio [χ 2 (1) Ͻ 0.001, n.s.]. Group characteristics are detailed in Table 1 .
Calculating estimated number of years to disease onset
The number of years to disease onset was estimated for the AR ϩ group using the regression equation provided by Data represent mean (SD). ARϩ ϭ Huntington's disease mutation carriers; AR -ϭ non-carriers; F : M ϭ female : male; NART-IQ ϭ IQ estimated from National Adult Reading Test (Nelson, 1982) . Rubinsztein et al. (1997) : log (age) ϭ a ϩ β(CAG repeat number), where a ϭ 6.15 (SE ϭ 0.095) and β ϭ -0.053 (SE ϭ 0.0021). This model was found by Rubinsztein et al. (1997) to account for 69% of the variation in the age at onset of Huntington's disease in a sample of 293 patients. Estimated years to onset for AR ϩ subjects was computed by subtracting their age from the estimate of age at onset calculated using the above regression equation.
The mean CAG repeat length (Ϯ SEM) in the AR ϩ subjects was 42.0 (2.9), the mean estimated age at onset was 49.7 (1.8), and the mean estimated years to onset was 10.7 (Ϯ 2.6).
Psychometric assessment
Subjects were administered a number of standard psychometric tests to examine basic linguistic function. These were the vocabulary and comprehension subtests of the Wechsler Adult Intelligence Scale-Revised (WAIS-R) (Wechsler Corporation, 1987) ; the Controlled Word Association Test of letter fluency (Benton and Hamsher, 1976) , in which subjects are asked to generate as many words as possible beginning with the letters F, A and S, in that order, allowing 1 min per letter, and a semantic fluency test (Hodges et al., 1992) in which subjects must generate the names of as many animals as possible in 90 s.
Computerized tests
All tests were taken from the CANTAB, a suite of computerized cognitive tasks run on a portable Carry I 486 microcomputer, fitted with a Datalux touch-sensitive screen. Subjects were seated comfortably,~0.5 m from the touchscreen, and it was explained to them that they would have to respond to stimuli presented on the monitor screen by touching them. In order to introduce subjects to the apparatus, they were initially given a 'motor screening task' in which they were asked to respond to a series of 10 flashing crosses presented at varying locations on the monitor screen by placing the index finger of their preferred hand on the centre of each cross. After completion of this task, subjects were given the following cognitive tasks in the order described below.
Pattern and spatial recognition
Two tasks designed to assess recognition memory for both patterns and spatial locations were administered (Sahakian et al., 1988) . In the pattern recognition task, subjects are presented with a series of 12 abstract patterns and their task is to remember them. Following a delay of 5 s, each pattern is re-presented in reverse order paired with a novel pattern, and subjects are asked to touch the pattern they have seen previously. This procedure is then repeated with a further 12 patterns.
In the spatial recognition task, five squares are presented sequentially in different locations around the screen. In the recognition phase, each location is re-presented paired with a novel location, and subjects are asked to touch the location where they have seen a square appear. This procedure is repeated a further three times.
Spatial span
This is a computerized version of the Corsi block span task (Milner, 1971) . Briefly, each trial begins with nine white boxes presented in fixed locations on the monitor screen (Owen et al., 1990) . Initially, two of the boxes change colour, one after the other, in a predetermined sequence. The end of the sequence is indicated by a tone. Subjects are then asked to point to the boxes in the order in which they have changed colour. After successful completion of a sequence, the number of boxes changing colour increases by one, up to a maximum of nine. The test is terminated when three consecutive failures occur at any one sequence length.
Spatial working memory
This is a test of spatial working memory for humans (Owen et al., 1990) , which is formally analogous to the Olton radial arm maze (Olton et al., 1979) , a task of spatial working memory for the rat. Both tasks require memory for locations already visited. In this task, subjects are required to search through a number of coloured boxes presented on the monitor screen (by touching each one), in order to find blue tokens which are hidden inside. On any one trial, only a single token is hidden in one of the boxes. Once found, the next token is hidden. The key instruction is that once a token has been found within a particular box, then that box will not be used again to hide a token. Two error types are possible. First, a subject may return to open a box in which a token has already been found (a 'between-search' error). Secondly, a subject may return to a box already opened and shown to be empty earlier in the same trial (a 'within-search' error). There are four trials with each of four, six and eight boxes. The task is scored according to the number of between-and within-search errors at each level of difficulty and also for the use of an efficient search strategy (Owen et al., 1990) . A particularly efficient strategy for completing this task is to follow a predetermined search sequence, starting with a particular box and then returning to start each new sequence with that same box as soon as a token is found (editing the sequence when a token is found in that box). The extent to which such a strategy is used is estimated from the number of search sequences starting with a novel box for just the more difficult six-and eight-box problems. The total of these scores provides a measure of strategy for each subject, a high score (many sequences starting with a novel box) representing poor use of a strategy and vice versa.
One-touch Tower of London
This task is a modified version of the CANTAB Tower of London task (Owen et al., 1995a) . Subjects are first trained with a number of problems from the original Tower of London task and then presented with the following modified task. Two sets of coloured balls appear on the screen, one in the upper half of the screen and one in the lower half. They are described to the subjects as 'snooker' or 'pool' balls as they appear to hang in vertical pockets. There are three pockets in each half of the screen, one capable of holding three balls, one able to hold two balls and one able to hold one ball. The numbers 1, 2, 3, 4 and 5 are printed in large boxes across the bottom of the screen. At the start of each trial, the upper and lower pockets appear empty on the screen. After a 1-s delay, a tone alerts the subject to the screen and a red ball, a blue ball and a green ball are placed in a predetermined arrangement in the pockets of the upper and lower displays. The subjects are instructed to examine the positions of the balls on the screen and then to imagine how they might rearrange the balls in the lower display to match the ones in the upper display, without actually moving any of the balls. For any given arrangement, the subjects are asked to find the solution that requires the minimum number of moves, and then to press the corresponding number on the bottom of the screen. If a subjects' first response is incorrect, she or he is required to try again until the correct number is selected. The importance of accuracy rather than speed of response is emphasized. Subjects are first given two one-move and two two-move practice problems, then 14 test trials of varying problem difficulty arranged in a constant, pseudorandom order.
Visual discrimination learning/attentional set shifting
A schematic representation of this task is given in Fig. 1 (see also Roberts et al., 1988; Downes et al., 1989) . The task requires subjects to learn a series of two-alternative, forced-choice visual discriminations using feedback provided automatically by the computer. The task is composed of nine stages presented in the same fixed order, starting with a simple discrimination and its reversal for stimuli varying in just one dimension (e.g. two different white-line configurations). A second, alternative dimension is then introduced (purple filled shapes) and compound discrimination and reversal are tested. To succeed, subjects must continue to respond to the previously relevant dimension whilst ignoring the presence of the new, irrelevant dimension. At the intradimensional shift (IDS) stage, novel exemplars of each of the two dimensions are introduced and subjects must continue to respond to one of the two exemplars from the previously relevant dimension. Following another reversal, the extradimensional shift (EDS) and its reversal are presented, again using novel exemplars of each stimulus dimension. In order to succeed at this stage, the subject must shift 'attentional set' to the previously irrelevant stimulus dimension, whilst ignoring the previously relevant dimension. The EDS stage is akin to a change in category in the WCST.
Data analysis
Test variables were compared using factorial analysis of variance (ANOVA) following appropriate transformations. The ANOVA model was a two-factor design with group and difficulty level as factors. Student's t test was applied to test the significance of differences between means where factorial ANOVA was not required. Where appropriate, Pearson product moment and Spearman rank order correlation coefficients were calculated. To maximize the probability of detecting a group difference if one existed (i.e. to minimize the probability of type II errors), alpha levels were not adjusted for multiple comparisons, in line with the literature on cognitive function in preclinical Huntington's disease.
Results

Psychometric assessment
The AR ϩ group had raw scores similar to the AR -group on both the vocabulary [t (48) Table 2 . To examine further the group effect on semantic verbal fluency, data were analysed using the scoring system devised by Roberts and Le Dorze (1994) . Firstly, the organization of responses was examined by counting the number of semantic clusters. A semantic cluster was defined as at least two consecutive words belonging to the same semantic subgroup (e.g. lion, tiger). A maximum semantic cluster length was also calculated for each subject. Finally, the number of repetitions (defined as the repetition of a word previously produced in the category) was calculated. AR ϩ subjects did not differ from AR -subjects on any of these measures. The mean number of clusters for AR ϩ subjects was 6.05 (SEM 0.38) and for AR -subjects it was 6.55 (0.46) [t(52) ϭ -0.80, P ϭ 0.43]. Mean maximum cluster length for AR ϩ subjects was 4.05 (SEM 0.24) and for AR -subjects it was 4.23 (0.18) [t(52) ϭ -0.60, P Ͼ 0.5]. The number of repetitions was negligible in both groups, and was not suitable for statistical analysis.
Motor screening
The AR ϩ group had somewhat slower mean response latencies than the AR -group [t(52) ϭ 1.88, P ϭ 0.07], although this did not reach statistical significance. Mean motor latency for the AR ϩ group (in seconds) was 1.34 (SEM 0.18) and for the AR -group it was 1.03 (0.06). 
Spatial span
The AR ϩ group did not differ significantly from the ARgroup in their spatial span length [t(48) ϭ -0.10, P Ͼ 0.5]. See Table 3 for mean scores.
Spatial working memory
The number of between-search errors made was subjected to repeated measures ANOVA with group and level (four, six or eight boxes) as factors, following square-root transformation [y ϭ √(x ϩ 0.5)], to equalize group variances. There was an effect of level [F(2,96) ϭ 64.55, P Ͻ 0.001] but no effect of group [F(1,48) Ͻ 1], and no interaction between group and level [F(2,96) Ͻ 1]. Data are presented in Table 4 . Within-search errors were at floor level for both groups, and were not suitable for statistical analysis.
Strategy scores also did not differ between the two groups [t(48) ϭ 1.47, P ϭ 0.15]. Mean strategy score for the AR ϩ group was 30.89 (SEM 1.42), and for the AR -group it was 28.00 (SEM 1.30). 
One-touch Tower of London
The main measure of planning accuracy was the mean number of attempts required before the correct solution for each level of difficulty. These data were subjected to repeated measures ANOVA with group and difficulty level as factors, following square root transformation [y ϭ √(x ϩ 0.5)]. There was a significant effect of difficulty level [F(4, 184) ϭ 19.55, P Ͻ 0.001] but no effect of group [F(1,46) Ͻ 1], and no interaction [F(4,186) Ͻ 1]. The data are presented in Table 5 . Mean latency for first responses was similarly analysed, following log 10 transformation. There was a significant effect of difficulty level [F(4,186) ϭ 115.4, P Ͻ 0.001], but no effect of group [F(1,46) Ͻ 1] and no interaction [F(4,186) Ͻ 1]. Data are presented in Table 6 .
Visual discrimination learning/attentional set shifting
The stages of interest were the IDS and EDS shift stages. Errors to criterion for each stage were square root-transformed [y ϭ √(x ϩ 0.5)] in order to meet the assumptions of parametric statistics. Repeated measures ANOVA with group and shift (IDS versus EDS) as factors revealed a significant effect of group [F(1,52) ϭ 4.94, P ϭ 0.03], a significant effect of shift [F(1,52) ϭ 59.69, P Ͻ 0.001], and a significant Group ϫ Shift interaction [F(1,52) ϭ 4.30, P ϭ 0.04]. Analysis of simple effects revealed that AR ϩ subjects made significantly more errors than AR -subjects on the EDS [F(1,52) ϭ 5.05, P ϭ 0.03] but not the IDS stage [F(1,52) ϭ 0.007, P Ͼ 0.9]. Data are presented graphically in Fig. 2 .
Mean response latencies were analysed in a similar fashion, following log 10 transformation. There was no effect of group [F(1,52) ϭ 1.55, P ϭ 0.22], no effect of shift [F(1,52) ϭ 0.43, P ϭ 0.52], and no interaction [F(1,52) ϭ 0.44, P ϭ 0.51]. For the AR ϩ group, latencies (in seconds) were: IDS ϭ 0.86 (SEM 0.22), EDS ϭ 1.73 (SEM 0.40). For the ARgroup, latencies (in seconds) were: IDS ϭ 1.06 (SEM 0.36), EDS ϭ 1.81 (SEM 0.12). 
Correlational analysis
Correlation coefficients were computed between cognitive and genetic/demographic variables for the AR ϩ group. There was a significant correlation between EDS errors and total score on the semantic verbal fluency test (r ϭ -0.40, P ϭ 0.04), partialling for age and NART-estimated IQ. Correlations between motor screening latencies and EDS errors (r ϭ 0.10) and semantic verbal fluency (r ϭ 0.08) were non-significant, suggesting that there was no relationship between subtle motor difficulties and cognitive impairment.
EDS errors did not correlate with age (r ϭ 0.27, n.s.) or with CAG expansion length (r ϭ 0.10, n.s.). Total scores on semantic verbal fluency also did not correlate with age (r ϭ -0.37, n.s.) or with CAG expansion length (r ϭ 0.06, n.s.). There was, however, a trend for both EDS errors (r ϭ -0.45, P Ͻ 0.1) and semantic verbal fluency scores (r ϭ 0.40, P Ͻ 0.1) to correlate with estimated years to onset, suggesting that cognitive impairment worsens nearer to the age at which clinical symptoms appear.
Discussion
This study has provided evidence for a specific pattern of cognitive impairment in preclinical Huntington's disease mutation carriers. Mutation carriers (AR ϩ ) performed significantly less well than non-carriers (AR -) on a test of semantic verbal fluency, and made significantly more errors at the EDS stage of the visual discrimination learning/ attentional set shifting task. Importantly, both of these tasks have been shown to be sensitive to early stage clinical Huntington's disease (Hodges et al., 1990; .
In contrast, the performance of mutation-positive subjects on tests of vocabulary, comprehension, letter fluency, shortterm visuospatial recognition memory, spatial span, spatial working memory and spatial planning, all of which are sensitive to clinical Huntington's disease (Butters, 1984; , was no different from that of mutationnegative subjects. These results thus point to a very specific difference in cognitive function between mutation carriers and non-carriers, and are important in staging the cognitive decline seen in Huntington's disease.
Relationship to previous findings in the literature
The finding of preclinical cognitive dysfunction in AR ϩ subjects is in accord with some findings (Jason et al., 1988; Diamond et al., 1992; Foroud et al., 1995; Rosenberg et al., 1995; Gray et al., 1997) , but not others (Strauss and Brandt, 1990; Blackmore et al., 1995; Giordani et al., 1995; Campodonico et al., 1996; de Boo et al., 1997) . There are a number of possible reasons for these discrepancies.
Perhaps the most likely explanation relates to differences in the populations examined. Early studies using the G8 linkage probe to determine high-versus low-risk subjects lost statistical power due to the presence of individuals in their at-risk samples who were not gene carriers and would therefore not be expected to show any cognitive impairment. However, this cannot be the only reason for failure to reject the null hypothesis, as later studies which have used direct gene testing with PCR have also reported no differences between AR ϩ and AR -subjects. It is of note that in the three studies using direct gene testing which have not found differences between AR ϩ and AR -groups, the mean age of the AR ϩ subjects was several years younger than those of the AR ϩ group in the present study. The mean ages of the AR ϩ subjects in the studies of Blackmore et al. (1995) , Giordani et al. (1995) and Campodonico et al. (1996) were in the low thirties, whereas those of Foroud et al. (1995) and Rosenberg et al. (1995) were in the middle to high thirties. One might well expect that any subtle differences in cognitive function between AR ϩ and AR -would become amplified as subjects approached the age at which clinical symptoms would manifest. It must be noted, however, that the patients studied by Campodonico et al. (1996) were on average 10 years from their estimated age of onset, similar to the AR ϩ subjects of the current study. It is unlikely, therefore, that differences in years to onset of clinical symptoms is responsible for all the discrepancies between studies.
At present, strict criteria for early motor symptoms in Huntington's disease do not exist, thus differences in inclusion criteria (e.g. presence/absence of neurological soft signs) may contribute to the discrepancies in the literature (de Boo et al., 1997) .
Other differences between this and other studies relate to the precise nature of the cognitive tests used. Thus, in the current study differences between the two groups were seen only on tests of semantic verbal fluency and attentional set shifting. Somewhat surprisingly, semantic verbal fluency has not previously been assessed in subjects at risk for Huntington's disease. Other investigators have found letter fluency to be unimpaired in AR ϩ subjects, in line with the current findings (Blackmore et al., 1995) .
The attentional set shifting task used in the current studies shares many similarities with the WCST. Jason et al. (1988) have previously found impaired WCST performance in a small group of subjects determined to be at high risk for Huntington's disease by use of the G8 probe. By contrast, Strauss and Brandt (1990) , Blackmore et al. (1995) , Rosenberg et al. (1995) , Campodonico et al. (1996) and de Boo et al. (1997) have found unimpaired performance on the WCST in AR ϩ subjects. However, The WCST is a multicomponent task, which can be solved using a variety of strategies, including matching to sample, and does not have the psychological and neural specificity of the attentional set-shifting task used in the current study (Downes et al., 1989; Grafman et al., 1990; Owen et al., 1991) . Thus, the current attentional set shifting task may rely more heavily on those cognitive processes which are vulnerable in Huntington's disease.
This explanation seems quite likely, given the lack of sensitivity of other tasks on which performance is compromised in early-stage clinical Huntington's disease Lawrence, 1997) . Pattern and spatial short-term recognition memory, spatial span, spatial working memory and spatial planning capacities were equivalent in the AR ϩ and AR -groups. Short-term visual memory has previously been found to be unimpaired in AR ϩ subjects (Blackmore et al., 1995; Giordani et al., 1995; Gomez-Tortosa et al., 1996) . Blackmore et al. (1995) found unimpaired performance on the Corsi span task in AR ϩ subjects, but self-ordered working memory and planning performance have not been rigorously assessed in AR ϩ subjects prior to the current study. Rosenberg et al. (1995) have found unimpaired performance in AR ϩ subjects on the Tower of Toronto task, which bears some procedural similarities to the current Tower of London task, but, since it does not require subjects to formulate the entire solution path before execution, it is not as stringent a test of 'on-line' planning as is the current Tower of London task (Goel and Grafman, 1995) . The finding of unimpaired performance on tasks as difficult as the spatial working memory task and the Tower of London task in the AR ϩ group suggests that task difficulty per se is not a sufficient explanation for impaired performance in the present group of AR ϩ subjects. Further, letter fluency is considered to be more 'effortful' than semantic verbal fluency (Martin et al., 1994) , and yet was not impaired in the AR ϩ subjects. Neither can differences in general intellectual function be the cause of such impairment. Estimated IQs were equivalent in the two groups, as was performance on subtests from the WAIS-R known to depend highly on general intelligence (Foroud et al., 1995) .
The nature of the cognitive dysfunction in Huntington's disease
The finding that AR ϩ subjects were impaired on both the attentional set-shifting task and semantic verbal fluency, apparently quite different tasks, raises the question of the nature of the cognitive dysfunction seen in AR ϩ subjects. It is important to note, however, that performances on the two tasks correlated significantly with each other, even controlling for the effects of age and estimated IQ.
Previous studies in Huntington's disease have tended to show a greater impairment of letter than semantic verbal fluency (for review, see Rosser and Hodges, 1994) . However, Barr and Brandt (1996) , in line with the current findings, found that Huntington's disease patients, regardless of dementia severity, were relatively more impaired on semantically guided verbal fluency than letter fluency. Patients with Huntington's disease do show deficits in semantic memory (Hodges et al., 1990) , but this is usually at a much later stage of the disease and is thought to reflect problems with retention and retrieval rather than semantic breakdown per se (Hodges et al., 1990; Rosser and Hodges, 1994) . In the present study, semantic verbal fluency was always assessed directly after letter fluency. Downes et al. (1993) have argued that having to generate exemplars from a semantic category after generating exemplars from a phonemic category can be conceptualized as an EDS, similar to that required in the attentional set shifting task. They found that patients with Parkinson's disease generated significantly fewer exemplars from a category when they were required to shift between using phonemic and semantic cues than when they had to alternate between different categories within the same domain (i.e. letter to letter or semantic category to semantic category). The finding in the current study that the number of exemplars generated in the semantic fluency task correlated negatively with EDS errors on the attentional set-shifting task, might indeed suggest that a unitary deficit is responsible for impaired performance on the semantic fluency and set-shifting tasks. Moreover, AR ϩ subjects showed no evidence of any impairment in using semantic clustering strategies on the fluency task, suggesting that they do not have any deficiencies in using organizational strategies or with the structure of semantic memory (see also Chan et al., 1995) .
What then, is the cause of the extradimensional shifting impairment seen in the AR ϩ subjects in the current study? One possibility is that the deficit is one of inhibitory control. Indeed, the striatum has long been implicated in the inhibition of unwanted responses (for reviews, see Rosvold, 1968; Mink, 1996) . Using a novel version of the visual discrimination learning/attentional set-shifting task (Owen et al., 1993) , it has been shown that the EDS impairment exhibited by clinically symptomatic Huntington's disease patients results from increased perseverative responding, Huntington's disease patients continuing to respond to the now irrelevant dimension (Lawrence, 1997) . This would appear to suggest a deficit in inhibitory control. Indeed, Huntington's disease patients have been shown to exhibit deficient inhibitory control in a number of neuropsychological paradigms (Oscar-Berman et al., 1980a, b; Josiassen et al., 1983; Georgiou et al., 1995 Georgiou et al., , 1996 Sprengelmeyer et al., 1995; Swerdlow et al., 1995) . Shifting from a phonetically based strategy for searching the lexicon to a semantic one can also be seen to require considerable inhibitory control (Downes et al., 1993) , and is therefore also sensitive to the cognitive disorder of Huntington's disease.
Thus, there appears to be considerable similarity between the role of the striatum in movement and cognition (Mink, 1996) , and a deficit in inhibitory control seems to be a cardinal feature of the cognitive disorder of Huntington's disease, manifesting itself prior to the onset of clinically identifiable movement disorder.
The staging of cognitive decline in Huntington's disease in relation to neuropathology
The present results suggest that a deficit in cognitive set may be present some time before the onset of clinical movement disorder. This has important consequences for the staging of cognitive decline in Huntington's disease.
The attentional set-shifting task appears particularly sensitive to the cognitive decline seen in Huntington's disease. With increasing disease severity one sees a graded change in performance on this task. Thus, whereas around one-third (eight out of 22) of AR ϩ subjects failed the test at the EDS stage, this increased to~75% in early-stage symptomatic Huntington's disease . Moreover, in more advanced stages of the disease, Huntington's disease patients showed pronounced deficits even at the simple reversal stage of the task .
A useful aspect of the present attentional set-shifting task is that it can be used in experimental primates to establish the necessary and sufficient neural systems for mediation of different stages of the task. Thus, importantly, experiments in the marmoset have shown that EDS and reversal impairments can be doubly dissociated following excitotoxic lesions to the lateral and orbital prefrontal cortex, respectively (Dias et al., 1996) . In a previous report , we related the progression from EDS to reversal impairments in Huntington's disease to the proposed dorsalventral progression of neuropathology throughout the striatum (Vonsattel et al., 1985; Hedreen and Folstein, 1995; Augood et al., 1996) . Inputs to the striatum are arranged in a parallel 'loop', the dorsal prefrontal cortex projecting to dorsal aspects of the caudate and the orbital prefrontal cortex projecting more ventrally (Alexander et al., 1986; Arikuni and Kubota, 1986) . Thus it would appear that those functions associated with the dorsal prefrontal cortex-striatal loop can be impaired even before the onset of clinical movement disorder in Huntington's disease, and that functions associated with the ventral loop become impaired as the wave of neuronal loss in the striatum progresses in a dorsal-to-ventral fashion.
The current finding fits in well with neuropathological data showing that neuronal damage can be present in the striatum prior to the onset of clinical symptoms in Huntington's disease (Albin et al., 1992) , and also with recent neuroimaging studies which have shown reduced basal ganglia volumes (Aylward et al., 1996) , glucose metabolism (Grafton et al., 1992; Antonini et al., 1996) and dopamine receptor binding (Antonini et al., 1996; Weeks et al., 1996) in AR ϩ subjects prior to overt clinical symptoms. Without measures of basal ganglia dysfunction against which cognitive performance can be correlated, we cannot say for certain whether the cognitive dysfunction seen in the present study results directly from striatal dysfunction. It is of note, however, that the attentional set-shifting task, but not spatial working memory or the Tower of London task, appears sensitive to preclinical Huntington's disease. Of the various CANTAB tasks, it is the attentional set shifting that is most sensitive to basal ganglia dysfunction, as seen for example in Parkinson's disease, whereas the spatial working memory task appears most sensitive to damage to the prefrontal cortex, as seen for example in neurosurgical patients with frontal lobe excisions (for review, see .
Of further importance is the finding of normal pattern recognition memory in preclinical Huntington's disease. This task is sensitive to the relatively early stages of clinical Huntington's disease and also to temporal lobe damage, but not frontal lobe damage (Owen et al., 1995b) . It is believed that the temporal lobe forms a similar loop structure with the tail of the caudate and putamen, as does the prefrontal cortex with the anterior striatum (Middleton and Strick, 1996) , and damage to the tail of the caudate-putamen in monkeys results in impaired discrimination of complex patterns (Divac et al., 1967; Buerger et al., 1974) . The finding of normal pattern recognition but impaired set shifting might suggest that those functions associated with the tail of the caudate-putamen are less sensitive to the earliest stages of Huntington's disease than those associated with more (dorsal) anterior sections of the striatum.
Relationship with CAG expansion size and years to onset
Of particular interest to Huntington's disease research are genotype-phenotype relations. In the present study, CAG repeat lengths were measured using a PCR assay which excluded the polymorphic CCG repeats flanking the CAG repeat on the Huntington's disease chromosome (Rubinsztein et al., 1993) , allowing accurate correlations between cognitive performance and CAG repeat length to be calculated. Previous studies have shown correlations between CAG repeat length and age at onset (Andrew et al., 1993; Rubinsztein et al., 1997) , neuronal loss at post-mortem examination (Furtado et al., 1996) , PET measures of striatal dysfunction (Antonini et al., 1996) and psychomotor speed (Foroud et al., 1995; Siemers et al., 1996) .
In the present study, no associations between CAG repeat length and cognitive dysfunction were found. This is most likely to be due to the relatively small sample size and the narrow range of expanded allele sizes found in the present study (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) . Indeed, the correlations between CAG length and age at onset are driven mainly by the large expansion sizes seen in juvenile onset cases (Andrew et al., 1993) , and the range of expansion sizes seen in the current study was associated with very variable age at onset.
There was a trend, however, for attentional set shifting and semantic verbal fluency performance to correlate with the estimated years to onset in the AR ϩ subjects, such that cognitive performance was worse in those subjects nearer to their expected age of onset. Using a prediction formula different from that used in this study, Aylward et al. (1996) found significant correlations between basal ganglia volumes, as measured by MRI, and estimated years to onset in AR ϩ subjects. Campodonico et al. (1996) reported a similar correlation with measures of psychomotor speed and estimated years to onset. These results suggest that striatal degeneration and cognitive impairment increase as subjects approach the age at which clinical symptoms manifest themselves.
The results of the current study suggest that the cognitive sequelae of basal ganglia dysfunction can be seen prior to the onset of overt clinical movement disorder in Huntington's disease, and thus point to a continuous rather than discontinuous mode of action of the Huntington's disease mutation. Bhide et al. (1996) have found mutant huntingtin to be present in the immature brain, and have raised the possibility that neurons may be affected during brain development, during the postnatal period when vulnerability to excitotoxic injury is at its peak. However, a partial loss of function of wild-type huntingtin resulting in reduced basal ganglia development cannot be ruled out.
It is important to note at this point that we are not suggesting that cognitive dysfunction is the initial manifestation of Huntington's disease. Affective disturbance may also be present prior to the onset of overt movement disorder in Huntington's disease (Folstein, 1989) . The relationship between the cognitive, motor and affective components of Huntington's disease is as yet unclear, and future studies are planned to look at this relationship in carriers of the Huntington's disease mutation.
Conclusions
The results of the present study are consistent with proposals that basal ganglia dysfunction may be evident in individuals who carry the Huntington's disease mutation prior to the onset of overt clinical movement disorder (Myers et al., 1991) and with other recent studies showing cognitive impairments in AR ϩ subjects (Foroud et al., 1995; Rosenberg et al., 1995; Siemers et al., 1996; Gray et al., 1997) and reduced basal ganglia volumes (Aylward et al., 1996) , glucose metabolism (Grafton et al., 1992; Antonini et al., 1996) and dopamine receptor binding (Antonini et al., 1996; Weeks et al., 1996) measured in vivo using MRI and PET.
Further, the results point to a specific pattern of cognitive impairment in Huntington's disease involving an impairment in shifting cognitive set, presumably resulting from a deficit in inhibitory control, and add to the weight of evidence linking the striatum to processes of control over responding (Buchwald et al., 1975; Robbins and Brown, 1990; Houk and Wise, 1995; Mink, 1996) . From a clinical perspective, we suggest that the attentional set-shifting task may be particularly useful in tracking the cognitive decline seen in Huntington's disease. The set-shifting task, representing the earliest sign of cognitive dysfunction in Huntington's disease, may also be useful not only in measuring the effects of therapeutic interventions, but also in determining when they should start. Further longitudinal studies are clearly required before firm conclusions can be reached regarding the staging of cognitive decline in individuals who carry the Huntington's disease mutation.
